Movement Disorders

Total Page:16

File Type:pdf, Size:1020Kb

Movement Disorders Movement Disorders Movement disorders are a group of conditions characterized by alteration in normal motility, posture or tone, alone or in combination. Changes caused by motor paralysis, severe sensory loss, painful syndromes or skeletal deformities, etc. are not included in these disorders. Though movement abnormalities may be seen with lesions of the cerebral hemispheres, cerebellum, and brainstem or in metabolic disorders, the most common site is the extrapyramidal system (basal ganglia). This is a phylogenetically older motor system and is responsible for regulation of tone, automatic movements and posture. The basal ganglia cannot produce fine voluntary movement in man, which is a function of the pyramidal system. The extrapyramidal system “sets the background for efficient functioning of the pyramidal system”. The manifestation of an extrapyramidal lesion depends on the role of a given part within the overall organization of the system. Whereas lesions of the substantia nigra often produce typical parkinsonism (with tremor, bradykinesia and rigidity), akinetic-rigid parkinsonism may be produced by lesions of the globus pallidus. Focal lesions in the caudate can produce chorea, while lesions in the putamen may cause dystonia. The clinical findings will be contralateral to the side of the lesion. Movement disorder manifestations are characterized as either hyperkinetic (increased movement) or hypokinetic (decreased movement). Hyperkinetic movement disorders include tremor, chorea, ballismus, athetosis, myoclonus, tics, and dyskinesias. Parkinsonism is a hypokinetic movement disorder, with overall paucity of movement, with the exception of tremor (hyperkinesia). Dystonia is also a 1 combination of hypokinesis and hyperkinesis, with the dominant picture of increased tone caused by agonist and antagonist co-contraction with rare dystonic tremor. All movement disorders are worsened with stress, fatigue, anxiety or concomitant illness (e.g. pneumonia, UTI, etc.). As a rule, movement disorders show significant or complete relief during sleep. Tremor Tremor is the most common movement disorder. It is defined as “an involuntary rhythmical movement about an axis.” It can involve any body part but most commonly affects the limbs or head. Everyone has physiological tremor but it is not clinically evident. Tremor is classified as follows: (1) Resting – Parkinsonian tremor. The limbs are fully supported against gravity i.e. patient lying supine on the examining table. (2) Postural – the body part held out against gravity i.e. hands out in front. Examples include: (a) exaggerated physiological tremor as seen with anxiety, thyrotoxicosis, caffeine, fatigue, etc.; (b) essential tremor; (c) cerebellar tremor (slow, and patient is also ataxic); (d) other metabolic disorders (including drug-induced) (3) Kinetic (Action) – with activity i.e. asked to perform finger/nose/finger. This type of tremor is seen in essential tremor. Tremor seen near the end of movement is also called “terminal” or “intention” tremor. Lesions in the cerebellar outflow tract are associated with prominent terminal tremor (as well as ataxia). Tics These are stereotyped, repetitive, rapid coordinated movements. They can involve any body part but typically involve the head, neck, eyes or upper extremities. The pattern is the same in a given patient. These movements can 2 be voluntarily suppressed but this causes a build-up of tension. When the tension is “released” there are exaggerated movements and the patient feels more comfortable. Tics may be simple or complex. Tic disorder is not uncommon in children but typically resolves spontaneously. The diagnosis of Tourette’s syndrome requires the presence of multiple motor and one or more vocal tics (e.g. grunting, sniffing, other vocalizations, etc.) lasting more than 1 year, with onset before age 18. There is an association between obsessive- compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD) and Tourette’s. Dystonia Dystonia is characterized by sustained muscle contractions resulting in abnormal movement or posture. The “dystonic movement” is brief, irregular, intermittent, twisting or turning in nature producing distortion of the involved part, hence the term “torsion dystonia”. Dystonia usually begins as a dystonic movement and further progression leads to sustained abnormal posture lasting for 30 seconds or longer – known as “dystonic posture”. Dystonia may involve any part of the body such as the neck (cervical dystonia, or torticollis), or the whole body as in dystonia musculorum deformans. In adults, dystonia is typically focal (most commonly cervical) while in childhood, dystonia is more often generalized. In most cases, the pathological basis of dystonic movement and dystonic posture is not known. Lesions that have been identified include the putamen or diffuse basal ganglia involvement. Dystonia may be classified as symptomatic, i.e. a component of another disease such as Wilson’s disease (disorder of copper metabolism) or idiopathic. Idiopathic dystonia may be sporadic or inherited as an autosomal dominant or recessive disorder. Acute or chronic dystonia may be caused by neuroleptics. 3 Blepharospasm is a form of cranial dystonia consisting of involuntary eye closure affecting the orbicularis oculi muscles. Initially there may be symptoms of increased blinking; in severe cases patients are rendered functionally blind from sustained eye closure. Writer’s cramp is the most common type of task-specific dystonia. The hand assumes a dystonic posture with writing, the handwriting becoming progressively more effortful and illegible the longer the person writes. Other activities such as typing are unaffected. Other task-specific dystonias include musician’s dystonia (such as playing the piano or violin), and golfing (the “yips” with putting). Task- specific dystonias are thought to be due to repeated movements resulting in abnormal sensorimotor integration. Botulinum toxin injections are useful for cranial and cervical dystonia, as well as focal dystonias. Botulinum toxin produces weakness by inhibiting presynaptic release of acetylcholine at the neuromuscular junction. Onset of benefit is typically within 1-2 weeks following the injection, and benefit lasts for approximately 3 months. Adverse effects may include weakness, dysphagia and dysarthria, however injections are generally well tolerated. Dopa-Responsive Dystonia (DRD) is an uncommon form of dystonia with onset in childhood or adolescence. It may be mistaken for cerebral palsy, with some patients wheelchair bound for years until correctly diagnosed and treated. There is a diurnal pattern, with dystonia typically worse in the afternoon or evening, and improvement after sleep. DRD is very sensitive to small amounts of levodopa – excellent response and long-term benefit is the rule. The rule is that any child with dystonia warrants a trial of levodopa. Chorea From the Greek word “dance”, chorea is characterized by involuntary, irregular, purposeless, asymmetrical, non-rhythmic movements. Sometimes patients 4 attempt to incorporate these movements into semi-voluntary movements (parakinesia) e.g. involuntary movement of the arm is incorporated in an attempt to scratch the head, etc. The anatomical substrate is varied – a lesion affecting the caudate, or diffuse cerebral hemisphere or subcortical dysfunction. The differential diagnosis of chorea includes: (1) Huntington’s Disease. This has autosomal dominant inheritance (chromosome 4p, trinucleotide CAG repeat expansion) and is the most common genetic cause of chorea. There is anticipation, with future generations developing earlier and more severe disease. In addition to chorea, personality change and progressive dementia are common features. (2) Sydenham’s Chorea. This is seen following streptococcal infection (usually in children) and is self-limited. It is also known as “St. Vitus’ dance”. (3) Metabolic/systemic conditions. These include Wilson’s disease, polycythemia, hypocalcemia, hypoglycemia, thyrotoxicosis. (4) Vascular/Autoimmune disease e.g. systemic lupus erythematosus. (5) Drugs/medications – includes cocaine, amphetamines, neuroleptics, calcium channel blockers, oral contraceptives. (There are many more entities associated with chorea, and it makes for an excellent Royal College Fellowship examination question.) Athetosis This means “without fixed position”. Athetosis is a relatively uncommon movement disorder. The movements are purposeless, bizarre, complex and writhing. There is lack of agonist and antagonist coordination. In comparison to chorea, the movements are slower, more sustained, writhing and “snakelike”. Abnormal posturing is often associated with voluntary movements i.e. outstretched hands may show extension of the thumb and fingers but flexion at the wrist and pronation of the forearm. The tone is often increased, but not as 5 pronounced as in dystonia. The most common site of lesion is the putamen and/or caudate. The most common causes of athetosis are: (1) birth trauma or neonatal asphyxia; (2) Wilson’s disease; (3) post-encephalitic; (4) kernicterus; and (5) carbon monoxide poisoning. (Note: this is more information than you will ever need about athetosis; in practice these movements are usually called “choreoathetoid”.) Dyskinesias These are abnormal movements, usually choreiform in nature, but sometimes with athetoid and dystonic movements as well. Dyskinesias are seen in some cases after prolonged use of neuroleptics and may become persistent (tardive
Recommended publications
  • Physiology of Basal Ganglia Disorders: an Overview
    LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES SILVERSIDES LECTURE Physiology of Basal Ganglia Disorders: An Overview Mark Hallett ABSTRACT: The pathophysiology of the movement disorders arising from basal ganglia disorders has been uncer­ tain, in part because of a lack of a good theory of how the basal ganglia contribute to normal voluntary movement. An hypothesis for basal ganglia function is proposed here based on recent advances in anatomy and physiology. Briefly, the model proposes that the purpose of the basal ganglia circuits is to select and inhibit specific motor synergies to carry out a desired action. The direct pathway is to select and the indirect pathway is to inhibit these synergies. The clinical and physiological features of Parkinson's disease, L-DOPA dyskinesias, Huntington's disease, dystonia and tic are reviewed. An explanation of these features is put forward based upon the model. RESUME: La physiologie des affections du noyau lenticulaire, du noyau caude, de I'avant-mur et du noyau amygdalien. La pathophysiologie des desordres du mouvement resultant d'affections du noyau lenticulaire, du noyau caude, de l'avant-mur et du noyau amygdalien est demeuree incertaine, en partie parce qu'il n'existe pas de bonne theorie expliquant le role de ces structures anatomiques dans le controle du mouvement volontaire normal. Nous proposons ici une hypothese sur leur fonction basee sur des progres recents en anatomie et en physiologie. En resume, le modele pro­ pose que leurs circuits ont pour fonction de selectionner et d'inhiber des synergies motrices specifiques pour ex£cuter Taction desiree. La voie directe est de selectionner et la voie indirecte est d'inhiber ces synergies.
    [Show full text]
  • Drug-Induced Movement Disorders
    Expert Opinion on Drug Safety ISSN: 1474-0338 (Print) 1744-764X (Online) Journal homepage: https://www.tandfonline.com/loi/ieds20 Drug-induced movement disorders Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivényi & László Vécsei To cite this article: Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivényi & László Vécsei (2015) Drug-induced movement disorders, Expert Opinion on Drug Safety, 14:6, 877-890, DOI: 10.1517/14740338.2015.1032244 To link to this article: https://doi.org/10.1517/14740338.2015.1032244 Published online: 16 May 2015. Submit your article to this journal Article views: 544 View Crossmark data Citing articles: 4 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ieds20 Review Drug-induced movement disorders Denes Za´dori, Ga´bor Veres, Levente Szala´rdy, Peter Klivenyi & † 1. Introduction La´szlo´ Vecsei † University of Szeged, Albert Szent-Gyorgyi€ Clinical Center, Department of Neurology, Faculty of 2. Methods Medicine, Szeged, Hungary 3. Drug-induced movement disorders Introduction: Drug-induced movement disorders (DIMDs) can be elicited by 4. Conclusions several kinds of pharmaceutical agents. The major groups of offending drugs include antidepressants, antipsychotics, antiepileptics, antimicrobials, antiar- 5. Expert opinion rhythmics, mood stabilisers and gastrointestinal drugs among others. Areas covered: This paper reviews literature covering each movement disor- der induced by commercially available pharmaceuticals. Considering the mag- nitude of the topic, only the most prominent examples of offending agents were reported in each paragraph paying a special attention to the brief description of the pathomechanism and therapeutic options if available. Expert opinion: As the treatment of some DIMDs is quite challenging, a pre- ventive approach is preferable.
    [Show full text]
  • Clinical Rating Scale for Pantothenate Kinase-Associated Neurodegeneration: a Pilot Study
    RESEARCH ARTICLE Clinical Rating Scale for Pantothenate Kinase-Associated Neurodegeneration: A Pilot Study Alejandra Darling, MD,1 Cristina Tello, PhD,2 Marı´a Josep Martı´, MD, PhD,3 Cristina Garrido, MD,4 Sergio Aguilera-Albesa, MD, PhD,5 Miguel Tomas Vila, MD,6 Itziar Gaston, MD,7 Marcos Madruga, MD,8 Luis Gonzalez Gutierrez, MD,9 Julio Ramos Lizana, MD,10 Montserrat Pujol, MD,11 Tania Gavilan Iglesias, MD,12 Kylee Tustin,13 Jean Pierre Lin, MD, PhD,13 Giovanna Zorzi, MD, PhD,14 Nardo Nardocci, MD, PhD,14 Loreto Martorell, PhD,15 Gustavo Lorenzo Sanz, MD,16 Fuencisla Gutierrez, MD,17 Pedro J. Garcı´a, MD,18 Lidia Vela, MD,19 Carlos Hernandez Lahoz, MD,20 Juan Darı´o Ortigoza Escobar, MD,1 Laura Martı´ Sanchez, 1 Fradique Moreira, MD ,21 Miguel Coelho, MD,22 Leonor Correia Guedes,23 Ana Castro Caldas, MD,24 Joaquim Ferreira, MD,22,23 Paula Pires, MD,24 Cristina Costa, MD,25 Paulo Rego, MD,26 Marina Magalhaes,~ MD,27 Marı´a Stamelou, MD,28,29 Daniel Cuadras Palleja, MD,30 Carmen Rodrı´guez-Blazquez, PhD,31 Pablo Martı´nez-Martı´n, MD, PhD,31 Vincenzo Lupo, PhD,2 Leonidas Stefanis, MD,28 Roser Pons, MD,32 Carmen Espinos, PhD,2 Teresa Temudo, MD, PhD,4 and Belen Perez Duenas,~ MD, PhD1,33* 1Unit of Pediatric Movement Disorders, Hospital Sant Joan de Deu, Barcelona, Spain 2Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigacion Prı´ncipe Felipe, Valencia, Spain 3Neurology Department, Hospital Clı´nic de Barcelona, Institut d’Investigacions Biomediques IDIBAPS.
    [Show full text]
  • Tardive Dyskinesia
    Tardive Dyskinesia Tardive Dyskinesia Checklist The checklist below can be used to help determine if you or someone you know may have signs associated with tardive dyskinesia and other movement disorders. Movement Description Observed? Rhythmic shaking of hands, jaw, head, or feet Yes Tremor A very rhythmic shaking at 3-6 beats per second usually indicates extrapyramidal symptoms or side effects (EPSE) of parkinsonism, even No if only visible in the tongue, jaw, hands, or legs. Sustained abnormal posture of neck or trunk Yes Dystonia Involuntary extension of the back or rotation of the neck over weeks or months is common in tardive dystonia. No Restless pacing, leg bouncing, or posture shifting Yes Akathisia Repetitive movements accompanied by a strong feeling of restlessness may indicate a medication side effect of akathisia. No Repeated stereotyped movements of the tongue, jaw, or lips Yes Examples include chewing movements, tongue darting, or lip pursing. TD is not rhythmic (i.e., not tremor). These mouth and tongue movements No are the most frequent signs of tardive dyskinesia. Tardive Writhing, twisting, dancing movements Yes Dyskinesia of fingers or toes Repetitive finger and toe movements are common in individuals with No tardive dyskinesia (and may appear to be similar to akathisia). Rocking, jerking, flexing, or thrusting of trunk or hips Yes Stereotyped movements of the trunk, hips, or pelvis may reflect tardive dyskinesia. No There are many kinds of abnormal movements in individuals receiving psychiatric medications and not all are because of drugs. If you answered “yes” to one or more of the items above, an evaluation by a psychiatrist or neurologist skilled in movement disorders may be warranted to determine the type of disorder and best treatment options.
    [Show full text]
  • The Rigid Form of Huntington's Disease U
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.24.1.71 on 1 February 1961. Downloaded from J. Neurol. Neurosurg. Psychiat., 1961, 24, 71. THE RIGID FORM OF HUNTINGTON'S DISEASE BY A. M. G. CAMPBELL, BERYL CORNER, R. M. NORMAN, and H. URICH From the Department ofNeurosurgery and Child Health, Bristol Royal Hospital, and the Burden Neuropathological Laboratory, Frenchay Hospital, Bristol Although the majority of cases of hereditary genetic study of Entres (1925) to belong to a typical chorea correspond accurately to the classical pattern Huntington family. More recent contributions are described by Huntington (1872), a number of those of Rotter (1932), Hempel (1938), and atypical forms have been recorded in children and Lindenberg (1960). Bielschowsky (1922) gave a adults which are characterized by rigidity rather detailed account of the pathological findings in a than by hyperkinesia. Most of these have been patient who was choreic at the age of 6 years and reported in the continental literature and we thought from the age of 9 gradually developed Parkinsonian it was of interest to draw attention to two atypical rigidity. Our own juvenile case is remarkable in juvenile cases occurring in an English family. From Reisner's (1944) review of these juvenile U cases the fact emerges that although the majority A present with typical choreiform movements, two Protected by copyright. atypical variants also occur: one in which the clinical picture is that of progressive extrapyramidal BC rigidity without involuntary movements, the other in which the disease starts as a hyperkinetic syn- drome and gradually changes into a hypokinetic one with progressive rigidity.
    [Show full text]
  • Clinical Manifestation of Juvenile and Pediatric HD Patients: a Retrospective Case Series
    brain sciences Article Clinical Manifestation of Juvenile and Pediatric HD Patients: A Retrospective Case Series 1, , 2, 2 1 Jannis Achenbach * y, Charlotte Thiels y, Thomas Lücke and Carsten Saft 1 Department of Neurology, Huntington Centre North Rhine-Westphalia, St. Josef-Hospital Bochum, Ruhr-University Bochum, 44791 Bochum, Germany; [email protected] 2 Department of Neuropaediatrics and Social Paediatrics, University Children’s Hospital, Ruhr-University Bochum, 44791 Bochum, Germany; [email protected] (C.T.); [email protected] (T.L.) * Correspondence: [email protected] These two authors contribute to this paper equally. y Received: 30 April 2020; Accepted: 1 June 2020; Published: 3 June 2020 Abstract: Background: Studies on the clinical manifestation and course of disease in children suffering from Huntington’s disease (HD) are rare. Case reports of juvenile HD (onset 20 years) describe ≤ heterogeneous motoric and non-motoric symptoms, often accompanied with a delay in diagnosis. We aimed to describe this rare group of patients, especially with regard to socio-medical aspects and individual or common treatment strategies. In addition, we differentiated between juvenile and the recently defined pediatric HD population (onset < 18 years). Methods: Out of 2593 individual HD patients treated within the last 25 years in the Huntington Centre, North Rhine-Westphalia (NRW), 32 subjects were analyzed with an early onset younger than 21 years (1.23%, juvenile) and 18 of them younger than 18 years of age (0.69%, pediatric). Results: Beside a high degree of school problems, irritability or aggressive behavior (62.5% of pediatric and 31.2% of juvenile cases), serious problems concerning the social and family background were reported in 25% of the pediatric cohort.
    [Show full text]
  • Vet Oracle Teleneurology: Client Factsheet
    Client Factsheet Paroxysmal Dyskinesia Paroxysmal Dyskinesia: A little bit of background Paroxysmal dyskinesias (PDs) are episodic movement disorders in which abnormal movements are present only during attacks. Although increasingly being recognised, they are often poorly characterised in veterinary literature and are commonly mistaken for an epileptic seizure, both by owners and by vets. The term ‘paroxysmal’ indicates that the signs occur suddenly against a background of normality. The term ‘dyskinesia’ broadly refers to a movement of the body that is involuntary, which means that the animal has no control over the movement and remains fully aware of its surroundings. Between attacks, affected animals are totally normal and there is no loss of consciousness during the attacks, though some animals may find the episodes disconcerting and do not respond normally. The attacks can last anything from a few minutes to a couple of hours and can sometime occur multiple times in a day. What causes Paroxysmal Dyskinesia? Most neurologists consider that PD results from dysfunction an area of the brain called the basal nuclei (often call the basal ganglia) and the cerebellum which is a fundamental part of the brain that involves in coordinating movement. Nerve cells in the basal nuclei play an important role in initiating and controlling movement. It is thought that abnormal signal from the cerebellum causes abnormal activity of the basal nuclei, which results in spontaneous and uncontrolled muscle activity and, therefore, movement and posture. The underlying cause of many PDs is unknown, with the majority being described as idiopathic (meaning of unknown cause) and presumed to be related to abnormal brain signalling between different parts involved with movement or its feedback control.
    [Show full text]
  • Rest Tremor Revisited: Parkinson's Disease and Other Disorders
    Chen et al. Translational Neurodegeneration (2017) 6:16 DOI 10.1186/s40035-017-0086-4 REVIEW Open Access Rest tremor revisited: Parkinson’s disease and other disorders Wei Chen1,2, Franziska Hopfner2, Jos Steffen Becktepe2 and Günther Deuschl1,2* Abstract Tremor is the most common movement disorder characterized by a rhythmical, involuntary oscillatory movement of a body part. Since distinct diseases can cause similar tremor manifestations and vice-versa,itischallengingtomakean accurate diagnosis. This applies particularly for tremor at rest. This entity was only rarely studied in the past, although a multitude of clinical studies on prevalence and clinical features of tremor in Parkinson’s disease (PD), essential tremor and dystonia, have been carried out. Monosymptomatic rest tremor has been further separated from tremor-dominated PD. Rest tremor is also found in dystonic tremor, essential tremor with a rest component, Holmes tremor and a few even rarer conditions. Dopamine transporter imaging and several electrophysiological methods provide additional clues for tremor differential diagnosis. New evidence from neuroimaging and electrophysiological studies has broadened our knowledge on the pathophysiology of Parkinsonian and non-Parkinsonian tremor. Large cohort studies are warranted in future to explore the nature course and biological basis of tremor in common tremor related disorders. Keywords: Tremor, Parkinson’s disease, Essential tremor, Dystonia, Pathophysiology Background and clinical correlates of tremor in common tremor re- Tremor is defined as a rhythmical, involuntary oscillatory lated disorders. Some practical clinical cues and ancillary movement of a body part [1]. Making an accurate diagnosis tests for clinical distinction are found [3]. Besides, accu- of tremor disorders is challenging, since similar clinical mulating structural and functional neuroimaging, as well entities may be caused by different diseases.
    [Show full text]
  • Diagnostic Clues in Multiple System Atrophy
    DO I:10.4274/Tnd.82905 Case Report / Olgu Sunumu Diagnostic Clues in Multiple System Atrophy: A Case Report and Literature Review Multisistem Atrofi Tanısında İpuçları: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi Mehmet Yücel, Oğuzhan Öz, Hakan Akgün, Semai Bek, Tayfun Kaşıkçı, İlter Uysal, Yaşar Kütükçü, Zeki Odabaşı Gülhane Military Medical Academy, Ankara, Turkey Sum mary Multiple system atrophy (MSA) is an adult-onset, sporadic, progressive neurodegenerative disease. Based on the consensus criteria, patients with MSA are clinically classified into cerebellar (MSA-C) and parkinsonian (MSA-P) subtypes. In addition to major diagnostic criteria including poor response to levodopa, and presence of pyramidal or cerebellar signs (ataxia) or autonomic failure, certain clinical features or ‘‘red flags’’ may raise the clinical suspicion for MSA. In our case report we present a 67-year-old female patient admitted to our hospital due to inability to walk, with poor response to levodopa therapy, whose neurological examination revealed severe Parkinsonism, ataxia and who fulfilled all criteria for MSA, as rarely seen in clinical practice.(Turkish Journal of Neurology 2013; 19:28-30) Key Words: Multiple system atrophy, autonomic failure, diagnostic criteria Özet Multisistem atrofi (MSA) erişkin dönemde başlayan, ilerleyici, nedeni bilinmeyen sporadik nörodejeneratif bir hastalıktır. MSA kabul görmüş tanı kriterlerine göre klinik olarak serebellar (MSA-C) ve parkinsoniyen (MSA-P) alt tiplerine ayrılmaktadır. Düşük levadopa yanıtı, piramidal, serebellar bulguların (ataksi) ya da otonomik bozukluk olması gibi majör tanı kriterlerininin yanında “red flags” olarak isimlendirilen belirgin klinik bulgular ya da uyarı işaretlerinin olması MSA tanısı için klinik şüpheyi oluşturmalıdır. Olgu sunumunda 67 yaşında yürüyememe şikayeti ile polikliniğimize müracaat eden ve levadopa tedavisine düşük yanıt gösteren ciddi parkinsonizm bulguları ile ataksi bulunan kadın hasta MSA tanı kriterlerini tam olarak karşıladığı ve klinik pratikte nadir görüldüğü için sunduk.
    [Show full text]
  • Restless Legs Syndrome: Keys to Recognition and Treatment
    REVIEW JAIME F. AVECILLAS, MD JOSEPH A. GOLISH, MD CARMEN GIANNINI, RN, BSN JOSÉ C. YATACO, MD Department of Pulmonary and Critical Department of Pulmonary and Critical Department of Pulmonary and Critical Care Department of Pulmonary and Critical Care Care Medicine, The Cleveland Clinic Care Medicine and Department of Medicine, The Cleveland Clinic Foundation Medicine, The Cleveland Clinic Foundation Foundation Neurology, The Cleveland Clinic Foundation Restless legs syndrome: Keys to recognition and treatment ■ ABSTRACT ESTLESS LEGS SYNDROME (RLS) is not a R new diagnosis: it was first described com- Restless legs syndrome (RLS) is a common and clinically prehensively 60 years ago.1 However, it con- significant motor disorder increasingly recognized by tinues to be underdiagnosed, underreported, physicians and the general public, yet still and undertreated. Effective therapies for this underdiagnosed, underreported, and undertreated. motor disorder are available, but a high index Effective therapies are available, but a high index of of suspicion is necessary to identify the condi- suspicion is required to make the diagnosis and start tion and start treatment in a timely fashion. treatment quickly. We now have enough data to support Evidence from clinical trials supports the the use of dopaminergic agents, benzodiazepines, use of dopaminergic agents, benzodiazepines, antiepileptics, and opioids in these patients. antiepileptics, and opioids in these patients. The clinician must be familiar with the benefits ■ KEY POINTS and risks of these therapies to be able to provide optimal treatment in patients with RLS. RLS is characterized by paresthesias, usually in the lower extremities. Patients often describe them as “achy” or ■ CLINICAL DEFINITION: “crawling” sensations.
    [Show full text]
  • Radiologic-Clinical Correlation Hemiballismus
    Radiologic-Clinical Correlation Hemiballismus James M. Provenzale and Michael A. Schwarzschild From the Departments of Radiology (J.M.P.), Duke University Medical Center, Durham, and f'leurology (M.A.S.), Massachusetts General Hospital, Boston Clinical History derived from the Greek word meaning "to A 65-year-old recently retired surgeon in throw," because the typical involuntary good health developed disinhibited behavior movements of the affected limbs resemble over the course of a few months, followed by the motions of throwing ( 1) . Such move­ onset of unintentional, forceful flinging move­ ments usually involve one side of the body ments of his right arm and leg. Magnetic res­ (hemiballismus) but may involve one ex­ onance imaging demonstrated a 1-cm rim­ tremity (monoballism), both legs (parabal­ enhancing mass in the left subthalamic lism), or all the extremities (biballism) (2, 3). region, which was of high signal intensity on The motions are centered around the shoul­ T2-weighted images (Figs 1A-E). Positive der and hip joints and have a forceful, flinging serum human immunodeficiency virus anti­ quality. Usually either the arm or the leg is gen and antibody titers were found, with predominantly involved. Although at least mildly elevated cerebrospinal fluid toxo­ some volitional control over the affected plasma titers. Anti-toxoplasmosis treatment limbs is still maintained, the involuntary with sulfadiazine and pyrimethamine was be­ movements typically can be checked by the gun, with resolution of the hemiballistic patient for only a few moments ( 1). The movements within a few weeks and decrease movements are usually continuous but may in size of the lesion.
    [Show full text]
  • THE MANAGEMENT of TREMOR Peter G Bain
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.72.suppl_1.i3 on 1 March 2002. Downloaded from THE MANAGEMENT OF TREMOR Peter G Bain *i3 J Neurol Neurosurg Psychiatry 2002;72(Suppl I):i3–i9 remor is defined as a rhythmical, involuntary oscillatory movement of a body part.1 The Tformulation of a clinical diagnosis for an individual’s tremor involves two discrete steps2: c The observed tremor is classified on phenomenological grounds c An attempt is made to find the cause of the tremor by looking for aetiological clues in the patient’s history and physical examination and also, in some cases, by investigation. c PHENOMENOLOGICAL CLASSIFICATION OF TREMOR The phenomenological classification of tremor is determined by finding out: c which parts of the patient’s body are affected by tremor? c what types (or components) of tremor, classified by state of activity, are present at those anatomical sites? The following definitions are used to describe the various tremor components evident on exam- ination1: c Rest tremor is a tremor present in a body part that is not voluntarily activated and is completely supported against gravity (ideally resting on a couch) copyright. c Action tremor is any tremor that is produced by voluntary contraction of a muscle. It includes pos- tural, kinetic, intention, task specific, and isometric tremor: – Postural tremor is present while voluntarily maintaining a position against gravity – Kinetic tremor is tremor occurring during any voluntary movement. Simple kinetic tremor occurs during voluntary movements that are not target directed – Intention tremor or tremor during target directed movement is present when tremor amplitude increases during visually guided movements towards a target at the termination of that movement, when the possibility of position specific tremor or postural tremor produced at the beginning and end of a movement has been excluded – Task specific kinetic tremor—kinetic tremor may appear or become exacerbated during specific activities.
    [Show full text]